These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9414637)

  • 1. Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia.
    Bruserud O; Ulvestad E; Halstensen A; Berentsen S; Bergheim J; Nesthus I
    Eur J Haematol; 1997 Nov; 59(5):269-76. PubMed ID: 9414637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
    Bruserud O
    Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T-cell proliferation.
    Bruserud O; Ulvestad E; Berentsen S; Bergheim J; Nesthus I
    Scand J Immunol; 1998 Jan; 47(1):54-62. PubMed ID: 9467659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin 6 in acute leukaemia patients with chemotherapy-induced leucopenia and bacterial infections.
    Bruserud O; Akselen PE; Bergheim J; Nesthus I
    Br J Haematol; 1995 Oct; 91(2):394-402. PubMed ID: 8547081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: characterization of T lymphocyte subsets responsive to IL-16 and IL-17.
    Bruserud O; von Volkman HL; Ulvestad E
    Acta Haematol; 2000; 104(2-3):80-91. PubMed ID: 11154979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells.
    Bruserud O
    Int J Immunopharmacol; 2000 Jan; 22(1):69-81. PubMed ID: 10684990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
    Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø
    Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of lymphocyte surface markers in childhood acute lymphoblastic leukemia during maintenance chemotherapy].
    Sugita K; Kurosawa H; Sakakibara H; Eguchi M; Furukawa T
    Gan To Kagaku Ryoho; 1992 May; 19(5):659-64. PubMed ID: 1580639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging.
    Rea IM; McNerlan SE; Alexander HD
    Exp Gerontol; 1999 Jan; 34(1):79-93. PubMed ID: 10197730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia.
    Bruserud O; Ulvestad E
    J Interferon Cytokine Res; 2000 Nov; 20(11):947-54. PubMed ID: 11096451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
    Bruserud O; Ulvestad E
    Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma.
    Asadullah K; Friedrich M; Döcke WD; Jahn S; Volk HD; Sterry W
    J Invest Dermatol; 1997 May; 108(5):743-7. PubMed ID: 9129226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells.
    Ersvaer E; Liseth K; Skavland J; Gjertsen BT; Bruserud Ø
    BMC Immunol; 2010 Jul; 11():38. PubMed ID: 20618967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy-induced leucopenia.
    Bruserud O; Aasen I; Akselsen PE; Bergheim J; Rasmussen G; Nesthus I
    Eur J Haematol; 1996 Jul; 57(1):87-95. PubMed ID: 8698137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes.
    Garrone P; Djossou O; Galizzi JP; Banchereau J
    Eur J Immunol; 1991 Jun; 21(6):1365-9. PubMed ID: 1828424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL2- and IL4-dependent proliferation of T-cell clones derived early after allogeneic bone marrow transplantation: studies of patients with chronic myelogenous leukaemia.
    Bruserud O; Hamann W; Patel S; Ehninger G; Pawelec G
    Eur J Haematol; 1992 Apr; 48(4):221-7. PubMed ID: 1350537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori.
    Karttunen R
    Clin Exp Immunol; 1991 Mar; 83(3):396-400. PubMed ID: 1900743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study of the expression of activation markers on T-lymphocyte subpopulations in different forms of bronchial asthma].
    Beda MV; Pavliuk AS; Veselova AV; Dement'eva EG; Solov'ev SS; Bart BIa; Koval'chuk LV
    Ter Arkh; 1995; 67(3):26-9. PubMed ID: 7770797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.